Back to search

Article

Induction of promyelocytic leukemia zinc finger protein by miR-200c-3p restores sensitivity to anti-androgen therapy in androgen-refractory prostate cancer and inhibits the cancer progression via down-regulation of integrin α3β4

2022-10-20

Abstract excerpt

<h4>Purpose: </h4> Androgen-refractory prostate cancer (ARPC) is one of the aggressive human cancers with metastatic capacity and resistance to androgen deprivation therapy (ADT). The present study investigated the genes responsible for ARPC progression and ADT resistance, and their regulatory mechanisms. Methods Transcriptome analysis, co-immunoprecipitation, confocal microscopy, and FACS analysis were performed...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
2a71b4f1-29f2-59b7-9896-ffe09ec7c7ab
DOI
10.21203/rs.3.rs-2171149/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Induction of promyelocytic leukemia zinc finger protein by miR-200c-3p restores sensitivity to anti-androgen therapy in androgen-refractory prostate cancer and inhibits the cancer progression via down-regulation of integrin α3β4DOI 10.21203/rs.3.rs-2171149/v1
Select a neighboring publication to make it the new centre.